ASX jumps on tariff relief, Wall Street ends strongly despite “Sell America” talk and Neuren and GGE take off.
The US Food & Drug Administration has approved EBR System’s leadless pacemaker WISE, the only device able to deliver left-ventricle stimulation.
The spectacular cyber attack on super was aimed at larger funds – but SMSFs are equally exposed to new risks – here’s what to do.
EBR Systems lands FDA approval for Wise CRT system, a world first solution proving pacing options for the left side of the heart.
Finnish explorer Nordic Resources has diversified into gold with a major deal that will see it acquire the 814,800oz gold equivalent Kopsa deposit.
